"Primary healthcare has very limited tools for detecting heart failure. We can create completely new treatment options for remote monitoring of at-risk groups and for monitoring already diagnosed patients after hospitalisation," says CardioSignal's founding member and CEO, Cardiologist Juuso Blomster.
Consistent with several European countries, heart failure affects around 1–2% of the population in Finland, but it is much more common in older adults, affecting around one in ten people aged 70. Detecting heart failure is important as effective treatment can help to alleviate its symptoms. Accurate diagnosis and timely access to treatment can also reduce healthcare costs, which are driven up by emergency room visits and hospital stays, especially during exacerbations.
The joint research projects between CardioSignal and the University of Turku aim to promote people's health and reduce healthcare costs through innovation, improved disease diagnostics, and prevention of serious complications.
Back to HCB News
